Luxembourg: CordenPharma completes acquisition of three manufacturing units from Vifor Pharma

Full-service international Contract Development & Manufacturing Organization (CDMO), CordenPharma, has completed the acquisition of three manufacturing facilities from Vifor Pharma. The financial terms behind the transaction were not released but Vifor Pharma’s divestment will trigger an asset impairment, to be reported with its 2021 financial results. Under the agreement, announced in December 2021, CordenPharma acquires…

You must be a HMI Subscriber to view this content.

Subscribe Now »